Leading The Way in Cutting-Edge Immunity Solutions

Innate Immunity has proudly created an interdisciplinary team pursuing our mission of solving big challenges facing human, plant, animal and industrial health.

Our team includes startup veterans, esteemed scientific, regulatory and legal rock stars and former big pharma drug development professionals with a track record of bringing therapeutics to market. We have also cultivated solid industry partnerships, national laboratory and university relationships supported by a cadre value-added angel and strategic investors.

Innate Immunity

Our Leadership

Innate immunity leaders are dedicated to advancing innovative solutions in the agricultural and biotechnology sectors.

Innate Immunity

Michelle D. Miller

Co-Founder, CEO, Chairman
With over 30 startups created and developed, Michelle is a seasoned entrepreneur in the biotech and medical device space. She has co-founded more than 20 companies, successfully raising over $100 million to accelerate growth and innovation in young enterprises. Her strategic vision and leadership drive our mission forward.
Innate Immunity

Mattson-Hoss, PhD

Director of Research and Development
As a key player in three biotech startups, Dr. Mattson-Hoss is focused on advancing our lead compound and developing the Innate Immunity peptide platform. With a proven track record, she has raised $3 million in grant funding, showcasing her commitment to fostering innovation and scientific excellence.
Innate Immunity

Patrick McDonnell

Innate Plant Lead
With over 30 years of experience in food and agricultural chemistry, Patrick brings extensive expertise in business development from leading ag-chem biofirms. Formerly in senior business development roles at BASF, Aventis Crop Science, and Biotalys, he leverages his deep industry knowledge to drive our initiatives in plant health and sustainability.

Key Team Members

Innate Immunity

Benjamin Berkowitz, PhD, JD

Dr. Berkowitz combines expertise in science and law, having served as a Senior Scientist at Los Alamos National Laboratory and as Senior EVP at Eli Lilly, where he helped launch Trulicity. He currently sits on the Innate Board of Directors.
Innate Immunity

Jurgen Schmidt, PhD

Dr. Schmidt specializes in drug development and has extensive experience in advancing therapeutic candidates from discovery to clinical stages. His leadership is essential to our innovative projects.
Innate Immunity

Pawel Fludzinski, PhD

Dr. Fludzinski focuses on peptide research in drug discovery. His innovative approach and expertise in biological chemistry enhance our ability to develop effective therapies.
Innate Immunity

Fred Betz

Fred Betz is a regulatory affairs expert and member of the Intellectual Property and Regulatory Advisory Council at Foley & Lardner. His experience ensures compliance and facilitates market access for our products.
Innate Immunity

Citrus Preservation Initiatives

Innate Immunity is at the forefront of national efforts to preserve not only the citrus industry but also the overall health of agricultural ecosystems. Our initiatives involve partnerships with leading scientific institutions and research projects dedicated to enhancing the resilience of various crops, including citrus. 

We aim to ensure the sustainability of citrus farming while simultaneously addressing the needs of diverse agricultural sectors.

Contact us today to learn more about our groundbreaking solutions and how we can support your efforts in preserving both citrus and other essential crops.